Stocks · Health care · Pharmaceutical Preparations

Clene Inc.

CLNN Clue Score16
United States Fiscal year ends December CIK 0001822791 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Robert Dee Etherington
29 Jul 2024
Chief Executive Officer
Exercised, kept
27,320
$3.00
$81.96K
Reed N Wilcox
14 Nov 2022
Director
Exercised, kept
174,912
$0.15
$26.24K
Reed N Wilcox
2 May 2022
Director
Exercised, kept
100,000
$0.15
$15.00K
John Henry Stevens
17 Feb 2022
Director
Exercised, kept
273,194
$0.53
$144.79K
Reed N Wilcox
20 Jan 2022
Director
Exercised, kept
253,000
$0.15
$37.95K
David J Matlin
6 Dec 2021
Director
Exercised, kept indirect
50,000
$0.01
$500.00
David J Matlin
6 Dec 2021
Director
Exercised, kept
12,500
$0.01
$125.00
Alison Mosca
1 Oct 2021
Director
Exercised, kept indirect
10,000
$0.01
$100.00
Alison Mosca
1 Oct 2021
Director
Exercised, kept indirect
15,000
$0.01
$150.00

What was left out

Form 4 filings counted 318
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 83
Transactions with no price 0
Shares from compensation/vesting 6,971,284
Sales filed before the plan box existed 6
History held since 3 Feb 2021